Therapeutic issues in lymphoproliferative disorders: Treatment and outcome of 28 cases observed in a single center

Author(s):  
Véronique Leblond ◽  
Richard Dorent ◽  
Marc-Olivier Bitker ◽  
Carole Soussain ◽  
Didier Samuel ◽  
...  
2012 ◽  
Vol 94 (10S) ◽  
pp. 761
Author(s):  
B. Kern ◽  
R. Sucher ◽  
I. Graziadei ◽  
C. Boesmueller ◽  
S. Scheidl ◽  
...  

2007 ◽  
Vol 82 (11) ◽  
pp. 1031-1031 ◽  
Author(s):  
Dino Veneri ◽  
Massimo Franchini ◽  
Roberta Zanotti ◽  
Francesco Frattini ◽  
Federica Randon ◽  
...  

2011 ◽  
Vol 26 (1) ◽  
pp. 67-73 ◽  
Author(s):  
Sun Och Yoon ◽  
Eunsil Yu ◽  
Yong Mee Cho ◽  
Cheolwon Suh ◽  
Kyung Mo Kim ◽  
...  

2015 ◽  
Vol 134 (3) ◽  
pp. 161-167 ◽  
Author(s):  
Nawal F. Alshehry ◽  
Mohammed Al-Huneini ◽  
Jeffrey H. Lipton ◽  
Fotios V. Michelis

Lymphoproliferative disorders presenting simultaneously with or subsequent to the occurrence of chronic myeloid leukemia (CML) have rarely been reported. Herein, we report 8 cases of a variety of lymphoproliferative conditions associated with CML at different times during the course of the disease. All 8 patients were treated with tyrosine kinase inhibitors at some point during the course of their illness. The literature regarding the uncommon association of these apparently unrelated disorders is reviewed as well as the possible underlying mechanisms that could be associated with this phenomenon.


2017 ◽  
Vol 5 (1) ◽  
pp. 670-678
Author(s):  
HaithamMohammed. Abdelbary. ◽  
◽  
YasminAhmedAbouEl. Magd. ◽  
GihanKamalShams. Eldin. ◽  
MohamedOsman. Azzazi. ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document